AFFITECH A/S

CVR14538372Opløst

Core data

Name
AFFITECH A/S
Address
Ole Maaløes Vej 3, 2200, København N
Founded
Oct 1, 1990
0 / 12014
Locations (P-units)
0
Branch
Forskning og eksperimentel udvikling indenfor bioteknologi (721100)

Keep track of AFFITECH A/S

Get an email when we detect changes to financial reports, ownership, management or property trades. Save yourself checking the company again.
Free account

Description

Affitech A/S (‘the Company’) is a biopharmaceutical company dedicated to the discovery and development of fully human antibody therapeutics against cancer and other serious diseases. The Parent Company is mainly a holding company and the Group does not have any significant activities other than maintenance of out-license and collaboration agreements entered into in prior years. The Affitech A/S Group comprises the Parent Company Affitech A/S and its fully-owned subsidiaries Affitech Research AS (Norway) and Actigen Ltd. (UK) (together referred to as ‘the Group’).

Financials

Reporting period
Revenue
306,740,000
Operating profit
295,528,000
Profit before tax
305,803,000
Net income
236,753,000
Total assets
789,864,000
Equity
713,213,000
Avg. employees
2
2020–2021

Unlock financial history

Datapublica Risk Score

Locked
Assesses the risk of financial distress using the company’s accounts, history, and connections.
Company score
0 · Low100 · High

What goes into the assessment

  • Financials

  • Accounts and history

  • Owners and management

  • Company and connections

Standard: Score and risk bandPro: Also a detailed explanation of the factors

Contact

From cvr.dk

Company
2320****Show full
**@affitech.comShow full

Founders

FounderRegistered as founderCurrent rolesOwnership
Henrik Irgang ElsnerRegistered as founderOct 1, 1990Current roles
—
Ownership
—
Søren MouritsenRegistered as founderOct 1, 1990Current roles
—
Ownership
—

People

No current people or role data available

Auditor

EY Godkendt RevisionspartnerselskabAuditorRasmus Bloch JespersenRoleState Authorised Public AccountantFromJul 12, 2022

Foreign legal entity

Ownership100 %Voting rights100 %FromDec 20, 2018ToJan 2, 2023

Foreign legal entity

Ownership100 %Voting rights100 %FromJun 4, 2013ToDec 20, 2018

Child companies

Ownership20–24.99 %Voting rights20 %FromJul 2, 2010ToApr 25, 2016

Official sources